Activation-induced Deaminase, AID, is Catalytically Active As a Monomer on Single-stranded DNA
Overview
Molecular Biology
Authors
Affiliations
Hypermutation and class switch recombination of immunoglobulin genes are antigen-activated mechanisms triggered by AID, a cytidine deaminase. AID deaminates cytidine residues in the DNA of the variable and the switch regions of the immunoglobulin locus. The resulting uracil induces error-prone DNA synthesis in the case of hypermutation or DNA breaks that activate non-homologous recombination in the case of class switch recombination. In vitro studies have demonstrated that AID deaminates single-stranded but not double-stranded substrates unless AID is in a complex with RPA and the substrate is actively undergoing transcription. However, it is not clear whether AID deaminates its substrates primarily as a monomer or as a higher order oligomer. To examine the oligomerization state of AID alone and in the presence of single-stranded DNA substrates of various structures, including loops embedded in double-stranded DNA, we used atomic force microscopy (AFM) to visualize AID protein alone or in complex with DNA. Surprisingly, AFM results indicate that most AID molecules exist as a monomer and that it binds single-stranded DNA substrates as a monomer at concentrations where efficient deamination of single-stranded DNA substrates occur. The rate of deamination, under conditions of excess and limiting protein, also imply that AID can deaminate single-stranded substrates as a monomer. These results imply that non-phosphorylated AID is catalytically active as a monomer on single-stranded DNA in vitro, including single-stranded DNA found in loops similar to those transiently formed in the immunoglobulin switch regions during transcription.
Targeted Mutagenesis in Yeast Using CRISPR/Cas9 and Hyperactive Cytidine and Adenine Deaminases.
Skrekas C, Limeta A, Siewers V, David F ACS Synth Biol. 2023; 12(8):2278-2289.
PMID: 37486333 PMC: 10443040. DOI: 10.1021/acssynbio.2c00690.
Barzak F, Ryan T, Kvach M, Kurup H, Aihara H, Harris R Viruses. 2021; 13(2).
PMID: 33673243 PMC: 7918907. DOI: 10.3390/v13020290.
HPV Meets APOBEC: New Players in Head and Neck Cancer.
Riva G, Albano C, Gugliesi F, Pasquero S, Castillo Pacheco S, Pecorari G Int J Mol Sci. 2021; 22(3).
PMID: 33573337 PMC: 7866819. DOI: 10.3390/ijms22031402.
APOBEC: A molecular driver in cervical cancer pathogenesis.
Revathidevi S, Murugan A, Nakaoka H, Inoue I, Munirajan A Cancer Lett. 2020; 496:104-116.
PMID: 33038491 PMC: 7539941. DOI: 10.1016/j.canlet.2020.10.004.
Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands.
Salter J, Smith H Trends Biochem Sci. 2018; 43(8):606-622.
PMID: 29803538 PMC: 6073885. DOI: 10.1016/j.tibs.2018.04.013.